Purchases and Sales Made in Q2 2025 in Kal Vista Pharmaceuticals, Inc. (KALV)
This table provides information about the institutional ownership of Kal Vista Pharmaceuticals, Inc. (KALV) during Q2 2025. The information is specifically focused on institutions that hold shares of KalVista Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2025
Q2 2025
|
Dafna Capital Management LLC
Los Angeles, CA |
SELL
|
- |
-171K- 22.68% |
$1.76M - $2.52M
|
582K
$7.13M
|
|
|
Aug 13, 2025
Q2 2025
|
Saturn V Capital Management LLC
Austin, TX |
SELL
|
- |
-192K- 75.38% |
$1.98M - $2.84M
|
62.8K
$769K
|
|
|
Aug 14, 2025
Q2 2025
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-206K- 60.46% |
$2.12M - $3.03M
|
134K
$1.65M
|
|
|
Aug 14, 2025
Q2 2025
|
Ubs Group Ag
|
SELL
|
- |
-235K- 46.26% |
$2.42M - $3.47M
|
273K
$3.34M
|
|
|
Aug 13, 2025
Q2 2025
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-313K- 36.07% |
$3.23M - $4.62M
|
555K
$6.8M
|
|
|
Aug 14, 2025
Q2 2025
|
Allostery Investments LP
Stamford, CT |
SELL
|
- |
-418K- 91.27% |
$4.32M - $6.17M
|
40K
$490K
|
|
|
Aug 14, 2025
Q2 2025
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-436K- 75.03% |
$4.5M - $6.44M
|
145K
$1.78M
|
|
|
Aug 12, 2025
Q2 2025
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-473K- 73.19% |
$4.88M - $6.98M
|
173K
$2.12M
|
|
|
Aug 14, 2025
Q2 2025
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-691K- 68.14% |
$7.13M - $10.2M
|
323K
$3.96M
|